MYELODYSPLASTIC SYNDROME
|
|
0.710 |
GeneticVariation
|
UNIPROT |
We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F and S34Y) or Q157 (Q157R and Q157P) in 11% of the patients with de novo myelodysplastic syndrome (MDS).
|
25311244 |
2015 |
MYELODYSPLASTIC SYNDROME
|
|
0.710 |
GeneticVariation
|
BEFREE |
We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F and S34Y) or Q157 (Q157R and Q157P) in 11% of the patients with de novo myelodysplastic syndrome (MDS).
|
25311244 |
2015 |
MYELODYSPLASTIC SYNDROME
|
|
0.710 |
GeneticVariation
|
UNIPROT |
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
|
22158538 |
2011 |
Leukemia, Myelocytic, Acute
|
|
0.700 |
GeneticVariation
|
CLINVAR |
U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
|
23029227 |
2012 |
Leukemia, Myelocytic, Acute
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
|
22158538 |
2011 |
Leukemia, Myelocytic, Acute
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
|
22158538 |
2011 |
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
|
|
0.010 |
GeneticVariation
|
BEFREE |
In the patient diagnosed with aCML in bone marrow study, two CSF3R mutations, (T618I and Y779*) a SETBP1 mutation (G870S) and an U2AF1 mutation (Q157P), were identified by high-coverage next-generation sequencing.
|
31692115 |
2020 |
Malignant Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
The cancer-associated U2AF35 470A>G (Q157R) mutation creates an in-frame alternative 5' splice site that impacts splicing regulation in Q157R patients.
|
28893951 |
2017 |
Primary malignant neoplasm
|
|
0.010 |
GeneticVariation
|
BEFREE |
The cancer-associated U2AF35 470A>G (Q157R) mutation creates an in-frame alternative 5' splice site that impacts splicing regulation in Q157R patients.
|
28893951 |
2017 |
Miller Dieker syndrome
|
|
0.010 |
GeneticVariation
|
BEFREE |
We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F and S34Y) or Q157 (Q157R and Q157P) in 11% of the patients with de novo myelodysplastic syndrome (MDS).
|
25311244 |
2015 |
de novo myelodysplastic syndromes
|
|
0.010 |
GeneticVariation
|
BEFREE |
We previously identified missense mutations in the U2AF1 splicing factor affecting codons S34 (S34F and S34Y) or Q157 (Q157R and Q157P) in 11% of the patients with de novo myelodysplastic syndrome (MDS).
|
25311244 |
2015 |
Leukemia, Myelomonocytic, Chronic
|
|
0.010 |
GeneticVariation
|
BEFREE |
In this study of 226 patients with chronic myelomonocytic leukemia (CMML), mutational frequencies were 40% for SRSF2 (all affecting P95), 6% for SF3B1 (primarily K700E) and 9% for U2AF35 (mostly S34F and Q157P/R).
|
23335386 |
2013 |